A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207-Reference-Cited by-同舟云学术

A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207

Published:2016-11 Issue:11 Volume:11 Page:2018-2021
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Wheatley-Price Paul,Chu Quincy,Bonomi Maria,Seely Jean,Gupta Ashish,Goss Glenwood,Hilton John,Feld Ronald,Lee Christopher W.,Goffin John R,Maksymiuk Andrew,Murray Nevin,Hagerman Linda,Bradbury Penelope A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Prognosis and prognostic factors of patients with mesothelioma: a population-based study;van der Bij;Br J Cancer,2012

2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

3. Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

4. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies;Hu-Lowe;Cancer Res,2011

5. A phase I study of the anti-activin receptor-like kinase 1 (ALK-1) monoclonal antibody PF-03446962 in patients with advanced solid tumors;Goff;Clin Cancer Res,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer;International Journal of Molecular Sciences;2024-06-05

2. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

3. Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study;BMC Medicine;2023-10-20

4. Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs;International Journal of Molecular Sciences;2023-09-03

5. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity;European Journal of Pharmacology;2023-05